Catalogo dei prodotti della ricerca

NICOLAZZO, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.072
EU - Europa 1.059
AS - Asia 311
AF - Africa 12
SA - Sud America 12
OC - Oceania 2
Totale 3.468
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.054
IT - Italia 686
SG - Singapore 122
IN - India 112
SE - Svezia 104
DE - Germania 81
CN - Cina 57
FI - Finlandia 48
FR - Francia 27
GB - Regno Unito 26
BG - Bulgaria 20
CA - Canada 16
TG - Togo 12
IE - Irlanda 11
UA - Ucraina 11
AR - Argentina 10
PL - Polonia 8
AL - Albania 6
CH - Svizzera 6
RO - Romania 6
BE - Belgio 4
HK - Hong Kong 4
JP - Giappone 4
NL - Olanda 4
ES - Italia 3
IL - Israele 3
JO - Giordania 2
MX - Messico 2
PK - Pakistan 2
RS - Serbia 2
VN - Vietnam 2
AU - Australia 1
BD - Bangladesh 1
BR - Brasile 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
GR - Grecia 1
IR - Iran 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 3.468
Salva come PNG Salva come JPEG
Città #
Fairfield 339
Rome 320
Chandler 193
Ashburn 185
Woodbridge 151
Seattle 132
Houston 127
Cambridge 111
Wilmington 97
Singapore 85
Ann Arbor 63
Princeton 56
Grafing 49
Dearborn 41
Lawrence 37
Plano 36
San Paolo di Civitate 36
San Diego 27
New York 26
Millbury 23
Boston 21
Sofia 20
Beijing 19
Fremont 18
Helsinki 18
Santa Clara 18
Milan 15
Andover 14
Lomé 12
Dublin 11
Naples 11
Federal 10
Toronto 10
Boardman 9
Cagliari 9
Bologna 8
Genoa 8
Los Angeles 8
Phoenix 8
Stockholm 7
Bari 6
Bremen 6
Caserta 6
Des Moines 6
Ottawa 6
Arezzo 5
Bern 5
Bühl 5
Guangzhou 5
Hefei 5
Kunming 5
Nanjing 5
Palermo 5
Southend 5
Argenta 4
Canterbury 4
Hong Kong 4
Imperia 4
Norwalk 4
Priverno 4
Redwood City 4
San Mateo 4
Warsaw 4
Auburn Hills 3
Frosinone 3
Indiana 3
Munich 3
Paris 3
Perugia 3
Pomezia 3
Aldershot 2
Amman 2
Ariccia 2
Bergamo 2
Brasschaat 2
Brussels 2
Castegnero 2
Castellammare Di Stabia 2
Cepagatti 2
Chatou 2
Chengdu 2
Chieti 2
Dallas 2
Florence 2
Formello 2
Frankfurt am Main 2
Hanoi 2
Hyderabad 2
Jacksonville 2
Kobe 2
Lahore 2
Lappeenranta 2
Legnano 2
London 2
Malmesbury 2
Mannheim 2
Modigliana 2
Nanchang 2
Padova 2
Parma 2
Totale 2.580
Salva come PNG Salva come JPEG
Nome #
Razionale per la biopsia liquida nel carcinoma del colon-retto: focus sulle cellule tumorali circolanti 152
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab 106
Transient disappearance of RAS mutant clones in plasma: A counterintuitive clinical use of EGFR inhibitors in RAS mutant metastatic colorectal cancer 101
Circulating tumor cells identify patients with super-high-risk non-muscle-invasive bladder cancer: updated outcome analysis of a prospective single-center trial 99
Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma 91
CIRCULATING TUMOR CELLS AND THEIR PROGNOSTICSIGNIFICANCE IN NON MUSCLE INVASIVE BLADDER CANCER:A CELLSEARCH ANALYSIS. 87
Circulating tumor cells in right-and left-sided colorectal cancer 86
EpCAM expressing circulating tumor cells in colorectal cancer 86
CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients 85
Circulating tumor cells count and characterization in a male breast cancer patient 82
Coexistence of three EGFR mutations in an NSCLC patient: A brief report 82
The rationale for liquid biopsy in colorectal cancer: a focus on circulating tumor cells 80
PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: a molecular shield to evade immune system? 78
A NEW MOLECULAR CHEMOSENSITIVITY TEST TO IMPROVE AND PREDICT EFFICACY OF INTRAVESICAL ADJUVANTTHERAPY IN NMIBC (NON MUSCLE INVASIVE BLADDER CANCER) 77
Prognostic role of circulating tumor cell trajectories in metastatic colorectal cancer 76
The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC) 76
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer 74
Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer 72
Molecular Characterization of Circulating Tumor Cells to Study Cancer Immunoevasion 71
Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer 70
Circulating tumor cells: from fiction to reality 67
Letter to the Editor: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy” 67
Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: Analysis in primary cell cultures of human prostate carcinoma 67
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study 67
Significance of Circulating Tumor Cells in Soft Tissue Sarcoma 65
RAS mutation conversion in bevacizumab-treated metastatic colorectal cancer patients: a liquid biopsy based study 65
Molecular Biomarkers according to Primary Tumor Location in Colorectal Cancer: Current Standard and New Insights 64
Circulating methylated DNA to monitor the dynamics of RAS mutation clearance in plasma from metastatic colorectal cancer patients 64
High risk non-muscle invasive bladder cancer: prognostic factor of circulating tumour cells. 62
Circulating tumor cells: Exploring intratumor heterogeneity of colorectal cancer 62
An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile 62
Molecular markers in circulating tumour cells from metastatic colorectal cancer patients 61
EpCAMlow circulating tumor cells: Gold in the waste 55
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature 55
Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells 54
Prognostic significance of survivin-expressing tumor cells in T1G3 bladder cancer 51
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis. 51
Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff? 51
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors 50
EVALUATION AND PROGNOSTIC FACTOR OF CIRCULATING TUMOR CELL IN NMIBC (NON-MUSCLE INVASIVE BLADDER CANCER) 50
Improving the Nuclear-Localized Androgen Receptor Splice Variant 7 Test 49
Prognostic factor of circulating tumor cells in high risk non-muscle invasive bladder cancer 49
Comparison of two blood-based genotyping tests to investigate the KRAS G12C mutation in patients with non-small-cell lung cancer at failure of first-line treatments 49
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients 48
Why the therapeutic impact of RAS mutation clearance in plasma ctDNA deserves to be further explored in metastatic colorectal cancer 48
HIGH-RISK NMIBC (NON-MUSCLE INVASIVE BLADDERCANCER): PROGNOSTIC VALUE OF CIRCULATINGTUMOR CELLS 48
Detection of circulating tumor cells in patients with laryngeal cancer using screencell: comparative pre- and post-operative analysis and association with prognosis 47
Circulating tumor cells lacking cytokeratin in breast cancer: the importance of being mesenchymal 47
Early Detection of Disease Progression in Metastatic Cancers: Could CTCs Improve RECIST Criteria? 46
An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer 45
SURVIVIN EXPRESSING CIRCULATING TUMOR CELLS IN NONMUSCHE INVASIVE BLADDER CANCER: A CELLECTION™ DYNABEADS ANALYSIS 44
Liquid Biopsy for Predicting Bacillus Calmette-Guérin Unresponsiveness in Non-muscle-invasive Bladder Cancer 41
Circulating tumor cells and "suspicious objects" evaluated through CellSearch® in metastatic renal cell carcinoma. 35
Circulating tumor cells isolation: The “post-EpCAM era” 32
New thiadiazoline and thiadiazole analogues of K858: antiproliferative activity in a model of prostate carcinoma 31
In vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity 26
Sequential isolation and characterization of single CTCs and large CTC clusters in metastatic colorectal cancer patients 25
Is cancer an intelligent species? 19
About RAS Mutation Clearance in Plasma ctDNA From RAS-Mutant Colorectal Cancer Patients 19
A Fast and Furious Liquid Biopsy Assay to Monitor Targeted Therapy Resistance 16
null 5
Totale 3.690
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.900
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.900
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020571 0 0 19 23 61 96 112 81 76 54 26 23
2020/2021430 35 40 20 14 44 43 3 29 39 122 32 9
2021/2022604 21 22 50 17 76 15 31 63 52 38 116 103
2022/2023711 120 137 48 88 75 65 27 44 39 14 36 18
2023/2024604 33 56 24 61 44 81 21 64 7 83 59 71
2024/2025180 46 99 35 0 0 0 0 0 0 0 0 0
Totale 3.690